Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C22H21N3O2 |
| Molecular Weight | 359.421 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=C(CCN2CCC3=C(C2)C4=C(O3)C=CC=C4)C(=O)N5C=CC=CC5=N1
InChI
InChIKey=ZYXHQIPQIKTEDI-UHFFFAOYSA-N
InChI=1S/C22H21N3O2/c1-15-16(22(26)25-11-5-4-8-21(25)23-15)9-12-24-13-10-20-18(14-24)17-6-2-3-7-19(17)27-20/h2-8,11H,9-10,12-14H2,1H3
Lusaperidone (R107474) is a potent and relatively selective alpha(2)-adrenoceptor antagonist. It was under clinical evaluation for the treatment of depression, characterized by anergia and lack of drive. However, further clinical development has been stopped. Radiolabeled lusaperidone may be used as a potential radioligand for studying alpha(2)-adrenoceptors using PET.
CNS Activity
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: P08913 Gene ID: 150.0 Gene Symbol: ADRA2A Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/16517171 |
0.13 nM [Ki] | ||
Target ID: P18825 Gene ID: 152.0 Gene Symbol: ADRA2C Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/16517171 |
0.15 nM [Ki] | ||
Target ID: P18089 Gene ID: 151.0 Gene Symbol: ADRA2B Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/16517171 |
1.0 nM [Ki] |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29710
Created by
admin on Wed Apr 02 07:40:11 GMT 2025 , Edited by admin on Wed Apr 02 07:40:11 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
7907
Created by
admin on Wed Apr 02 07:40:11 GMT 2025 , Edited by admin on Wed Apr 02 07:40:11 GMT 2025
|
PRIMARY | |||
|
C90760
Created by
admin on Wed Apr 02 07:40:11 GMT 2025 , Edited by admin on Wed Apr 02 07:40:11 GMT 2025
|
PRIMARY | |||
|
300000037035
Created by
admin on Wed Apr 02 07:40:11 GMT 2025 , Edited by admin on Wed Apr 02 07:40:11 GMT 2025
|
PRIMARY | |||
|
DTXSID30175735
Created by
admin on Wed Apr 02 07:40:11 GMT 2025 , Edited by admin on Wed Apr 02 07:40:11 GMT 2025
|
PRIMARY | |||
|
3045401
Created by
admin on Wed Apr 02 07:40:11 GMT 2025 , Edited by admin on Wed Apr 02 07:40:11 GMT 2025
|
PRIMARY | |||
|
CHEMBL162501
Created by
admin on Wed Apr 02 07:40:11 GMT 2025 , Edited by admin on Wed Apr 02 07:40:11 GMT 2025
|
PRIMARY | |||
|
214548-46-6
Created by
admin on Wed Apr 02 07:40:11 GMT 2025 , Edited by admin on Wed Apr 02 07:40:11 GMT 2025
|
PRIMARY | |||
|
5KTD2O86CB
Created by
admin on Wed Apr 02 07:40:11 GMT 2025 , Edited by admin on Wed Apr 02 07:40:11 GMT 2025
|
PRIMARY |
ACTIVE MOIETY